VERU INC. Sale Leaseback Transaction, Current Period Gain Recognized
VERU INC. (VERU) reported Sale Leaseback Transaction, Current Period Gain Recognized of $657.61 thousand for the 12-month period ending 2010-09-30, per its 10-K filed 2012-12-04.
Discontinued › Income Statement › Other Income
us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized · last filed 2012-12-04
- VERU INC. sale leaseback transaction, current period gain recognized for fiscal 2010 was $657.61K.
| Period end | Sale Leaseback Transaction, Current Period Gain Recognized 12 month |
|---|---|
| 2010-09-30 | $657.61K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |